Earnings Preview For Ascendis Pharma
Portfolio Pulse from Benzinga Insights
Ascendis Pharma (NASDAQ:ASND) is set to release its latest quarterly earnings report on Tuesday, 2023-09-05. Analysts estimate an earnings per share (EPS) of $-2.77. Investors will be looking for an earnings beat and positive guidance for the next quarter. The company's shares were trading at $98.02 as of August 31, with a 52-week increase of 11.53%.
September 04, 2023 | 2:00 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Ascendis Pharma's upcoming earnings report could impact its stock price. An earnings beat and positive guidance could drive the price up, while a miss could lead to a decrease.
The company's stock price could be influenced by its earnings report. If the company beats the estimated EPS and provides positive guidance, the stock price could increase. Conversely, if the company misses the estimate, the stock price could decrease. However, it's also important to note that other factors could also influence the stock price.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100